OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Kevin E. Noonan, Ph.D, is a Partner with McDonnell Boehnen Hulbert & Berghoff LLP. He can be reached at email@example.com.
Kevin E. Noonan asks, what do the biosimilars provisions of the Trans-Pacific Partnership portend for global biologic drug development?